K Watanabe et al. Clin Gastroenterol Hepatol 2018; 16: 542-9.
The DIAMOND study evaluated monotherapy with adalimumab (n=85) compared with combination therapy of adalimumab with azathioprine (n=91).
- In this subanalysis of patients with moderate and severe Crohn’s disease (CD), endoscopic response (defined by SES-CD drop of at least 8 points or SES-CD <4) was significantly higher at week 26: 71.6% vs 54.4%. The OR for endoscopic response was 2.12 at week 26 with combination therapy.
- At week 52 the endoscopic response difference was not statistically significant: 60% vs. 50%.
- Similarly, mucosal healing was more common (but not statistically significant) in the combination group compared with monotherapy: 20.9% vs 103% at week 26, and 21.5% vs 12.2% at week 52.
- While not statistically significant, the combination group had ADA trough that was higher (7.6 compared with 6.5).
My take: The results described above for endoscopic responses and mucosal healing rates are depicted in figure 2 (I do not have a digital copy of figure or permission to use). After one looks at this figure, depicting the data noted above, there certainly appears to be an advantage for the use of combination therapy in patients with moderate-to-severe CD.
Related blog posts:
I have not independently verified the claims on this tweet
Increasingly, kidney problems are recognized in children with intestinal failure/short bowel syndrome who receive long-term parenteral nutrition. A recent study (H Billing et al JPGN 2018; 66: 751-54) highlights the experience with this issue at a pediatric intestinal rehabilitation center in Germany.
- Among 50 patients with a median age of 4.2 years, 76% had proteinuria
- 30% had chronic kidney disease –indicated by reduced creatinine clearance of <90 min (1.73 squared)/min
- Hypercalciuria was identified in 30 patients (60%)
- Nephrocalcinosis was identified in 9 patients (18%)
The authors note that end-stage renal failure has not been reported in association with intestinal failure, though proteinuria is associated as a risk factor.
My take: This observational study shows a high frequency of kidney issues in children with intestinal failure. With improvements in survival, chronic kidney disease could become a more significant clinical issue.
Tweet below indicates need for careful nutrition input when children are placed on unusual diets, including the ketogenic diet.
Yesterday, I was fortunate to participate in Crohn’s and Colitis Foundation of America (CCFA) “Take Steps” walk with a big contingent of our team. A shout out to Melissa Sheffer who was honored as Adult Volunteer of the year and to Jacqueline Akin who was honored as a pediatric hero.
Melissa along with Dr. Larry Saripkin (not pictured but also at event/walk) have been the crucial volunteers to run Camp Oasis for the last 14 years. Jacqueline said in her speech that she is followed by our team and also described some of the issues she has faced in trying to manage Crohn’s disease.
Also, I want to thank Jacob Schoeff and Dr. Dinesh Patel for team leadership and organizing our participation. Great work!
For those so inclined, it’s not too late to donate to our CCFA team: CCFA Super Poopers Donation Link
Briefly noted: T Martensson et al. JPGN 2018; 66: 744-50.
This retrospective study with 44 children (81 procedures) examined the yield of endoscopy for graft-versus-host disease (GVHD). They found that sigmoidoscopy had a sensitivity of 85% whereas Ileocolonoscopy OR combined EGD-sigmoidoscopy both had a sensitivity of 97.4%. The authors, thus, advocate more extensive evaluation in the majority of children with possible GVHD. “Sigmoidoscopy may be an approach to consider in severely ill children with contraindications to full endoscopy, for example, general anesthesia.”
Related blog post: Image Only: GVHD
Big Creek Greenway, near McFarland
From ImproveCareNow: Resources for Mind Body Interventions
The above linked-website has links to many others for patients and providers: meditation, mindfulness, yoga and guided imagery. The links on this page borrowed from Chelly Dykes and KT Park who credits Dr. Sindu Vellanki and Dr Ann Ming Yeh from Stanford.
Literature on these topics (also from ImproveCareNow): Mind Body Interventions and IBD
Mind Body Interventions and IBD – Journal Articles
- Yeh, A. M., Wren, A., & Golianu, B. (2017). Mind–Body Interventions for Pediatric Inflammatory Bowel Disease. Children, 4(4), 22. doi:10.3390/children4040022
- Mindfulness/ Meditation/ Mindfulness based Stress Reduction (MBSR):
- Kabat-Zinn, J., Lipworth, L., Burney, R., & Sellers, W. (1987). Four-Year Follow-Up of a Meditation-Based Program for the Self-Regulation of Chronic Pain: Treatment Outcomes and Compliance. The Clinical Journal of Pain, 3(1), 60.
**Note: This is an overview of MBSR, not IBD specific
- Neilson, K., Ftanou, M., Monshat, K., Salzberg, M., Bell, S., Kamm, M. A., . . . Castle, D. (2016). A Controlled Study of a Group Mindfulness Intervention for Individuals Living With Inflammatory Bowel Disease. Inflammatory Bowel Diseases, 22(3), 694-701.
- Jedel, S., Hoffman, A., Merriman, P., Swanson, B., Voigt, R., Rajan, K., . . . Keshavarzian, A. (2014). A Randomized Controlled Trial of Mindfulness-Based Stress Reduction to Prevent Flare-Up in Patients with Inactive Ulcerative Colitis. Digestion, 89(2), 142-155.
- Hood, M. M., & Jedel, S. (2017). Mindfulness-Based Interventions in Inflammatory Bowel Disease. Gastroenterology Clinics of North America, 46(4), 859-874.
- Berrill, J. W., Sadlier, M., Hood, K., & Green, J. T. (2014). Mindfulness-based therapy for inflammatory bowel disease patients with functional abdominal symptoms or high perceived stress levels. Journal of Crohns and Colitis,8(9), 945-955. doi:10.1016/j.crohns.2014.01.018
- Gerbarg, P. L., Jacob, V. E., Stevens, L., Bosworth, B. P., Chabouni, F., Defilippis, E. M., . . . Scherl, E. J. (2015). The Effect of Breathing, Movement, and Meditation on Psychological and Physical Symptoms and Inflammatory Biomarkers in Inflammatory Bowel Disease.Inflammatory Bowel Diseases,21(12), 2886-2896.
- Keefer, L., Taft, T. H., Kiebles, J. L., Martinovich, Z., Barrett, T. A., & Palsson, O. S. (2013). Gut-directed hypnotherapy significantly augments clinical remission in quiescent ulcerative colitis. Alimentary Pharmacology & Therapeutics,38(7), 761-771.
- Mawdsley, J. E., Jenkins, D. G., Macey, M. G., Langmead, L., & Rampton, D. S. (2008). The Effect of Hypnosis on Systemic and Rectal Mucosal Measures of Inflammation in Ulcerative Colitis. The American Journal of Gastroenterology,103(6), 1460-1469.
- Shaoul, R., Sukhotnik, I., & Mogilner, J. (2009). Hypnosis as an Adjuvant Treatment for Children With Inflammatory Bowel Disease. Journal of Developmental & Behavioral Pediatrics,30(3), 268.
- Vlieger, A., Govers, A., Frankenhuis, C., & Benninga, M. (2010). Hypnotherapy for children with functional abdominal pain or irritable bowel syndrome: Long term follow-up. European Journal of Integrative Medicine,2(4), 191.
IBS + Yoga:
- Schumann, D., Anheyer, D., Lauche, R., Dobos, G. Langhorst, J., Cramer, H. Effect of Yoga in the Therapy of Irritable Bowel Syndrome: A Systematic Review. Clin. Gastroenterol. Hepatol. 2016, 14, 1720-1731.
- Selvan, S. R., Kavuri, V., Selvan, P., Malamud, A., & Raghuram, N. (2015). Randomized clinical trial study of Yoga therapy for Irritable Bowel Syndrome (IBS). European Journal of Integrative Medicine,7, 23.
- Kuttner, L., Chambers, C., Hardial, J., Israel, D., Jacobson, K., Evans, K. A Randomized Trial of Yoga for Adolescents with Irritable Bowel Syndrome. Pain Research & Management 2006, 11, 217-223.
- Evans, S., Lung, K., Seidman, L., Sternlieb, B., Zeltzer, L., & Tsao, J. (2014). (567) Iyengar yoga for adolescents and young adults with irritable bowel syndrome (IBS). J. Pediatri. Gastroenterol. Nutri. 2014, 59, 244-253.
IBD + Yoga:
- Sharma, P., Poojary, G., Dwivedi, S. N., & Deepak, K. K. (2015). Effect of Yoga-Based Intervention in Patients with Inflammatory Bowel Disease. International Journal of Yoga Therapy,25(1), 101-112.
- Alicia Leiby (abstract only, not published) http://acgblog.org/2014/10/14/a-randomized-controlled-trial-of-yoga-in-pediatric-inflammatory-bowel-disease-preliminary-findings/
- Arruda, J., Bogetz, A., Wren, A., Vellanki, S., Yeh, AM. Is yoga an acceptable adjunctive therapy in the treatment of adolescents with inflammatory bowel disease? Manuscript in Preparation.
Briefly noted: Y Hanada et al. Clin Gastroenterol Hepatol 2018; 16: 528-33.
In this retrospective review with 9247 patients with IBD, the incidence of bacterial pathogens (non-C diff) identified was <3% of those who were tested; in this group (n=25), Aeromonas was detected in 8,Salmonella in 7, Plesiomonas in 4, Campylobacter in 2, and Yersinia in 2. From authors: “These infections did not have a significant negative impact on patient outcomes. Given these findings, routine testing for infections other than CDI is not recommended.”